Overview
Seer provides the Proteograph product suite, an integrated solution for unbiased deep proteomics analysis using engineered nanoparticles, automation instruments, and software. It enables biomarker discovery, target identification, and multiomics research for cancer, neurodegenerative, and metabolic diseases. Seer partners with service providers worldwide and collaborates with Thermo Fisher Scientific to promote its technology alongside Orbitrap Astral mass spectrometers.
Frequently asked questions
- What proteomics capabilities does Seer offer?
- Seer offers the Proteograph suite for deep, unbiased proteomics, including automation instruments, proprietary nanoparticles, and analysis software for biomarker discovery and multiomics in cancer, neurodegeneration, and metabolic diseases.
- What are Seer's key partnerships and integrations?
- Seer has a co-marketing agreement with Thermo Fisher Scientific to pair Proteograph with Orbitrap Astral mass spectrometers and partners with select global service providers to scale proteomics adoption.
- What applications does Seer's technology support?
- Applications include target identification, biomarker discovery for complex diseases, and complementing genomics data in pharma, biotech, academic labs, and CROs.